Analog Devices CFO Richard C. Puccio Jr sells 1,500 common shares for $631,620

Bitget2026/10/07 20:53

Analog Devices CFO Richard C. Puccio Jr sold 1,500 shares of common stock on Oct. 6, 2026. Sale price USD 421.08 per share. Directly held stake fell to 49,677 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Analog Devices Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002009110-26-000011), on October 07, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Simwon America (SWA.US) applies for Nasdaq IPO, plans to raise up to $50 million

Simwon America, a manufacturer of structural components for electric vehicles, filed for an IPO with the U.S. Securities and Exchange Commission (SEC) last Friday, aiming to raise up to $50 million. The company is a spinoff of Korea’s MS Autotech.

智通财经•2026/10/12 07:43

Sui Foundation Invests $30M in DATA Network as It Moves to Sui post-167040 post-167040 post-167040

Newscrypto•2026/10/12 07:18

Equities: Stable oil and yields support stock gains - Danske Bank

FXStreet•2026/10/12 07:12

Dental caries treatment provider vVardis (VVVV.US) submits US IPO application, expected to raise 200 million USD

vVardis Holding filed for an initial public offering (IPO) with the U.S. Securities and Exchange Commission (SEC) last Friday. The company focuses on self-developed non-invasive restorative therapies for the early treatment of dental caries. The IPO is expected to raise 200 millions USD.

智通财经•2026/10/12 07:07